PATENT CLAIM ANALYSIS

Application Number: 15945858
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["530", "300000"]

Abstract:
The present invention relates to a use of a human small leucine zipper protein in the osteogenesis procedure. More specifically, sLZIP increases the transcriptional activity of Runx2 and inhibits the transcriptional activity of PPARγ2, thereby increasing the osteoblast differentiation, so that sLZIP performs an important role in the osteogenesis procedure, and thus can be used as a marker for treating bone disease and developing new medicines.

Claim (Index 4):
The screening method of  claim 1 , wherein detecting is carried out by a reaction using the detectable component, or the human sLZIP or PPAR\u03b32-specific antibody.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.38462
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15692789', '14888343', '14888340', '10524919', '09987701']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7005324064802563
- 35 USC 102 Novelty (BERT): 0.6273914841953085
- Combined Prediction Score: 0.6932183142517615
- Mean Citation Score: 413.304634
- Max Citation Score: 554.7329
- Similarity Product: 548.4757442242146

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test